Pharmacology 6
Opoid analgesics
Question # 1 (Multiple Choice) Least addiction/abuse liability:
A) hydromorphone B) oxycodone C) nalbuphine D) codeine E) methadone
Question # 2 (Multiple Answer) Choose (the) pure narcotic antagonist(s):
A) pentazocine B) naloxone C) naltrexone D) codeine E) nallorphine
Question # 3 (Multiple Answer) Possible mechanisms responsible for opioid-mediated flushing and warming of the skin:
A) alpha1 receptor activation B) histamine release C) central effects D) adenosine receptor blockade E) inhibition of nitric oxide synthase
Question # 4 (Multiple Answer) Reverses opioid-mediated truncal rigidity:
A) IV fentanyl B) naltrexone C) succinylcholine D) nalmefene E) oxycodone
Question # 5 (True/False) relatively long-lasting narcotic antagonist
A) naloxone B) nalmefene
Question # 6 (Multiple Answer) Rationale for I.V. morphine to manage dyspnea secondary to acute pulmonary edema:
A) reduce perception of shortness of breath B) decrease preload C) decreased afterload D) decrease heart rate E) increase ventilation rate
Question # 7 (Multiple Answer) Prescribed to manage diarrhea
A) alfentanil B) difenoxin C) loperamide D) diphenoxylate E) hydromorphone
Question # 8 (Multiple Choice) Pain most effectively relieved by opioid agonists:
A) severe, constant pain B) intermittent sharp pain
Question # 9 (Multiple Choice) Most current opioid analgesics act at this opioid receptor subtype:
A) sigma B) kappa C) delta D) epsilon E) mu
Question # 10 (Multiple Answer) Pure narcotic antagonists:
A) nalbuphine B) naltrexone C) fentanyl D) pentazocine E) naloxone
Answers
Question # 1 (Multiple Choice) Least addiction/abuse liability:
Answer: (C) nalbuphine
Question # 2 (Multiple Answer) Choose (the) pure narcotic antagonist(s):
(B) naloxone
(C) naltrexone
Question # 3 (Multiple Answer) Possible mechanisms responsible for opioid-mediated flushing and warming of the skin:
(B) histamine release
(C) central effects
Question # 4 (Multiple Answer) Reverses opioid-mediated truncal rigidity:
(B) naltrexone
(C) succinylcholine
(D) nalmefene
Question # 5 (True/False) relatively long-lasting narcotic antagonist
Answer: False
Question # 6 (Multiple Answer) Rationale for I.V. morphine to manage dyspnea secondary to acute pulmonary edema:
(A) reduce perception of shortness of breath
(B) decrease preload
(C) decreased afterload
Qestion # 7 (Multiple Answer) Prescribed to manage diarrhea
(B) difenoxin
(C) loperamide
(D) diphenoxylate
Question # 8 (Multiple Choice) Pain most effectively relieved by opioid agonists:
Answer: (A) severe, constant pain
Question # 9 (Multiple Choice) Most current opioid analgesics act at this opioid receptor subtype:
Answer: (E) mu
Question # 10 (Multiple Answer) Pure narcotic antagonists:
(B) naltrexone
(E) naloxone
Management of coagulation disorders
Question # 1 (Multiple Answer) Excessive anticoagulant effect in bleeding due to warfarin can be reversed by:
A) stopping the drug B) large doses of vitamin K C) factor IX concentrates D) cholestyramine E) diuretics
Question # 2 (Multiple Answer) Protease inhibitor(s) that inactivators coagulation proteins escaping from sites of vessel injury:
A) alpha2-macroglobulin B) alpha2-antiplasmin C) antithrombin III D) alpha1 antiprotease E) streptokinase
Question # 3 (Multiple Choice) Cutaneous necrosis was reduced protein C activity occurs during the first weeks of therapy with:
A) streptokinase B) abciximab C) warfarin D) ticlopidine E) aspirin
Question # 4 (Multiple Answer) Coagulation Factor(s) targets of heparin:
A) fibrinogen B) proaccelerin C) prothrombin D) Christmas factor E) antihemophilic globulin (AHG)
Question # 5 (Multiple Choice) Thrombus type most likely to be formed in low pressure veins
A) white thrombus B) red thrombus
Question # 6 (True/False) Warfarin crosses the placental barrier:
A) true B) false
Question # 7 (Multiple Choice) Synonym for factor VII:
A) proaccelerin B) prothrombin C) proconvertin D) Christmas factor E) Fibrin-stabilizing factor
Question # 8 (Multiple Answer) Fibrolytic drugs:
A) streptokinase B) alteplase C) reteplase D) urokinase E) cyclooxygenase
Question # 9 (Multiple Choice) Immediate hemostatic responds to the damage vessel:
A) platelet adhesion B) platelet aggregation C) platelet viscous metamorphosis D) vasospasm E) white thrombus formation
Question # 10 (Multiple Answer) Coumarin anticoagulants resulted in biologically inactive forms of:
A) factor VII B) factor IX C) factor X D) anticoagulant protein C E) anticoagulant protein S
Question # 11 (Multiple Answer) Increases prothrombin time:
A) cimetadine B) metronidazole C) trimethoprim-sulfamethoxazole D) fluconazole E) disulfram
Question # 12 (Multiple Choice) Mouse/human chimeric monoclonal antibody -- blocks IIb/IIIb platelet receptor
A) ticlopidine B) timolol C) abciximab D) eicosapentaenoic acid E) streptokinase
Answers
Question # 1 (Multiple Answer) Excessive anticoagulant effect in bleeding due to warfarin can be reversed by:
(A) stopping the drug
(B) large doses of vitamin K
(C) factor IX concentrates
Question # 2 (Multiple Answer) Protease inhibitor(s) that inactivators coagulation proteins escaping from sites of vessel injury:
(A) alpha2-macroglobulin
(B) alpha2-antiplasmin
(C) antithrombin III
(D) alpha1 antiprotease
Question # 3 (Multiple Choice) Cutaneous necrosis was reduced protein C activity occurs during the first weeks of therapy with:
Answer: (C) warfarin
Question # 4 (Multiple Answer) Coagulation Factor(s) targets of heparin:
(C) prothrombin
(D) Christmas factor
Question # 5 (Multiple Choice) Thrombus type most likely to be formed in low pressure veins
Answer: (B) red thrombus
Question # 6 (True/False) Warfarin crosses the placental barrier:
Answer: True
Question # 7 (Multiple Choice) Synonym for factor VII:
Answer: (C) proconvertin
Question # 8 (Multiple Answer) Fibrolytic drugs:
(A) streptokinase
(B) alteplase
(C) reteplase
(D) urokinase
Question # 9 (Multiple Choice) Immediate hemostatic responds to the damage vessel:
Answer: (D) vasospasm
Question # 10 (Multiple Answer) Coumarin anticoagulants resulted in biologically inactive forms of:
(A) factor VII
(B) factor IX
(C) factor X
(D) anticoagulant protein C
Question # 11 (Multiple Answer) Increases prothrombin time:
(A) cimetadine
(B) metronidazole
(C) trimethoprim-sulfamethoxazole
(D) fluconazole
(E) disulfram
Question # 12 (Multiple Choice) Mouse/human chimeric monoclonal antibody -- blocks IIb/IIIb platelet receptor
Answer: (C) abciximab
|